Mutation detail:
| Mutation site | 29744G>A |
| Virus | SARS-CoV-2 |
Mutation level  |
Nucleotide level |
| Gene/protein/region type | 3'UTR |
| Gene ID | - |
| Country | - |
| Mutation type |
- |
| Genotype/subtype/clade | - |
| Sample |
Human |
| Variants | - |
| Viral reference sequence | MN908947.3 |
| Drug/antibody/vaccine | - |
| Transmissibility |
- |
| Transmission mechanism | - |
| Pathogenicity |
- |
| Pathogenicity mechanism | - |
| Immune escape mutation | - |
| Immune escape mechanism | - |
| RT-PCR primers probes | - |
Protein detail:
| Protein name | - |
| Uniprot protein ID | - |
| Protein length | - |
| Protein description | - |
Literature information:
| Pubmed ID | 33932525 |
| Clinical information | No |
| Disease | - |
| Published year | 2021 |
| Journal | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE |
| Title | Genome sequencing of SARS-CoV-2 in a cohort of Egyptian patients revealed mutation hotspots that are related to clinical outcomes |
| Author | Abdel-Rahman N Zekri, Marwa Mohanad, Mohammed M Hafez, Hany K Soliman, Zainab K Hassan |
| Evidence | Sequence reads were mapped to the SARS-CoV-2 genome Refseq (MN908947.3), revealing a total of 126 mutations. |